NEWS TIPS & FEATURES

Roswell Park Researchers Offer Novel Insight into Genetic Changes Leading to Cancer

Findings may lead to personalized prognostic tests for blood disorders Predisposition to cancer and cancer progression can result from gene mutations that cause elevated rates of genetic damage. Similarly,... [...]


Comprehensive Study of Esophageal Cancer Reveals Several Molecular Subtypes, Provides New Insight into Increasingly Prevalent Disease

A comprehensive analysis of 559 esophageal and gastric cancer samples, collected from patients around the world, suggests the two main types of esophageal cancer differ markedly in their molecular characteristics... [...]


Many Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through Families

One in every six colorectal cancer patients (16 percent) diagnosed under age 50 has at least one inherited genetic mutation that increases his or her cancer risk and many of these mutations could go undetected... [...]


Gradalis Announces a Novel Combination Study of Vigil® EATC in Women with Advanced Ovarian Cancer

Gradalis, Inc. a clinical stage cellular immunotherapy company, developing Vigil® Engineered Autologous Tumor Cell (EATC) therapy, announced that it has entered into a collaboration agreement with Genentech,... [...]


Do Social Connections Lower Death Rates from Breast Cancer?

Women diagnosed with breast cancer have greater rates of survival and lower rates of disease recurrences if they have more social ties, compared to women who are more socially isolated. These results were... [...]


Keytruda®/Halaven® Combo May Be Effective in Advanced Triple-Negative Breast Cancer

The investigative treatment combination including Keytruda® (pembrolizumab) plus Halaven® (eribulin) could provide a potential therapeutic option for patients with advanced triple-negative breast cancer... [...]


CTI BioPharma Announces Removal Of Full Clinical Hold On Pacritinib

CTI BioPharma Corp. announced that the full clinical hold (February 2016) implemented by the U.S. Food and Drug Administration (FDA) on all clinical trials conducted under the Investigational New Drug... [...]


ASTRO Expands Guidelines for Treatment of Breast Cancer with Accelerated Partial Breast Irradiation

According to the American Society for Radiation Oncology (ASTRO) younger patients with early stage breast cancer and individuals with low-risk ductal carcinoma in situ (DCIS) can appropriately be treated... [...]


Gazyva® Delays Cancer Progression as Initial Therapy in Advanced Follicular Lymphoma

Among patients with advanced follicular lymphoma who have not received prior therapy, treatment with Gazyva® (obinutuzumab) plus chemotherapy delays cancer progression compared to the standard Rituxan®... [...]


« More News Tips & Features

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS